We then focused the comparison of CNAs on known driver oncogenes located within regions frequently amplified in breast cancer: ERBB2 (17q12), CCND1 (11q13.3), FGFR1 (8p11.23), MYC (8q24), and PAK1 (11q14.1). This evidence concerns the gene FGFR1 and breast carcinoma.